These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23710969)

  • 1. Pharmacophore modelling and electronic feature analysis of hydroxamic acid derivatives, the HIV integrase inhibitors.
    Sangeetha B; Muthukumaran R; Amutha R
    SAR QSAR Environ Res; 2013; 24(9):753-71. PubMed ID: 23710969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
    Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
    Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
    J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
    Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
    J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
    Reddy KK; Singh SK
    Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
    Dayam R; Sanchez T; Neamati N
    J Med Chem; 2005 Dec; 48(25):8009-15. PubMed ID: 16335925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching.
    Nicklaus MC; Neamati N; Hong H; Mazumder A; Sunder S; Chen J; Milne GW; Pommier Y
    J Med Chem; 1997 Mar; 40(6):920-9. PubMed ID: 9083480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
    Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
    J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore development and docking studies of the hiv-1 integrase inhibitors derived from N-methylpyrimidones, Dihydroxypyrimidines, and bicyclic pyrimidinones.
    Telvekar VN; Patel KN
    Chem Biol Drug Des; 2011 Jul; 78(1):150-60. PubMed ID: 21518263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
    Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
    Gupta P; Garg P; Roy N
    Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR study of curcumine derivatives as HIV-1 integrase inhibitors.
    Gupta P; Sharma A; Garg P; Roy N
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):141-50. PubMed ID: 23286784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.
    Sun XH; Guan JQ; Tan JJ; Liu C; Wang CX
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):683-703. PubMed ID: 22991976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies.
    Reddy KK; Singh SK; Tripathi SK; Selvaraj C
    SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for potential HIV-integrase inhibitors identified using pharmacophore-based virtual screening and molecular dynamics studies.
    Islam MA; Pillay TS
    Mol Biosyst; 2016 Mar; 12(3):982-93. PubMed ID: 26809073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster analysis and three-dimensional QSAR studies of HIV-1 integrase inhibitors.
    Yuan H; Parrill A
    J Mol Graph Model; 2005 Jan; 23(4):317-28. PubMed ID: 15670952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.